目錄:MedChemExpress LLC>>信號通路>> BMS-470539 dihydrochloride | MCE
CAS | 2341796-82-3 | 純度 | 99.95% |
---|---|---|---|
分子量 | 632.62 | 分子式 | C??H??Cl?N?O? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mg |
貨號 | HY-115644 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
產(chǎn)品活性:BMS-470539 dihydrochloride 是一種高效的選擇性黑皮質(zhì)素 1 受體 (MC-1 R) 激動劑,IC50 為 120 nM,EC50 為 28 nM。BMS-470539 dihydrochloride 不激活 MC-3R,并且對 MC-4R 和 MC-5R 的激活活性非常弱。BMS-470539 dihydrochloride 具有強效的抗炎特性。
研究領(lǐng)域:GPCR/G Protein | Neuronal Signaling
作用靶點:Melanocortin Receptor
In Vitro: An HBL melanoma cell line is established that stably expresses a NF-κB luciferase reporter. In these cells, 0.5 ng/mL TNF-α induces a dose-dependent increase in NF-κB luciferase activity. Treatment of HBL-NF-κB cells with BMS-470539 elicits a dose-dependent, statistically significant reduction in TNF-α-stimulated NF-κB luciferase activity. BMS-470539 has no effect on luciferase reporter activity in the absence of TNF-α stimulation. In nontransfected HBL cells, treatment with BMS-470539 results in a dose-dependent inhibition of NF-B nuclear translocation.
In Vivo: BMS-470539 (2.05-18.47 mg/kg; intravenous injection; for 125 minutes; WT and MC1 receptor recessive e/e mice) treatment inhibits cell adhesion and emigration with no effect on cell rolling. And also inhibits the tissue expression of both CXCL1 and CCL2.
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Immunology/Inflammation Compound Library | Neuronal Signaling Compound Library | Anti-Obesity Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | PG106 | Bremelanotide | ACTH (3-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) | ACTH (11-24) | Adrenocorticotropic Hormone (ACTH) (1-39), human(TFA) | MK-0493 | HS024 | Melanotan I acetate | Agouti-related Protein (AGRP) (83-132) Amide (human) | JNJ-10229570 | MCL0020 | MC-4R Agonist 1 | HS014 | [D-Trp8]-γ-MSH | (D-Phe7)-α-MSH | PG-931 | JKC363 | (-)-Isodocarpin | SHU 9119 | Adrenocorticotropic Hormone (ACTH) (1-39), rat | CCZ01048 TFA | β-Melanocyte Stimulating Hormone (MSH), human TFA | RO27-3225 TFA | γ-1-Melanocyte Stimulating Hormone (MSH), amide | ACTH (1-17) (TFA) | Terrein | γ1-MSH TFA
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫,我們致力于為全球科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng);
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學(xué)分析檢測分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學(xué)研究進展,為您提供全球新的活性化合物;
• 與世界各大制藥公司及著名科研機構(gòu)建立了長期的合作。
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)